距移植中心的地理距离对等待名单结局及列名前后医疗资源利用的影响
研究基于加拿大安大略省伦敦市移植数据库,纳入2012年1月1日至2021年12月31日等待肝移植的成人患者,分析距移植中心距离是否影响等待名单死亡与肝移植获得。多变量分析显示距离不影响移植获得、等待名单死亡或列名后急诊就诊与住院,但距中心较远的患者在列名前一年住院和急诊次数更高。
要点
- 距移植中心距离不影响等待名单死亡率或肝移植获得。
- 距中心>150 km患者在列名前一年住院次数中位数更高(2 vs 1,P=0.02)。
- 距中心>150 km患者列名后90天内急诊利用更高,但多变量分析不一致。
核心结论
- 地理距离不显著影响肝移植等待名单死亡率或肝移植获得,但医疗资源利用的差异提示在移植前阶段仍可能存在对患者不利的差异。
研究设计与样本
- 研究人群来自加拿大安大略省伦敦市的移植数据库,纳入2012年1月1日至2021年12月31日等待肝移植的成人患者,数据与临床评估科学研究所链接,以≤150 km vs >150 km分层进行描述性分析,并采用多变量时间至事件分析评估距移植中心距离增加对等待名单死亡和肝移植获得的危害。
主要发现
- 552例符合研究标准患者中394例(71.4%)接受了肝移植,队列以男性为主(n=390,70%),中位年龄59岁(IQR 52-64),距移植中心中位距离110 km(IQR 59-191)。
- 距移植中心≤150 km(n=362)与>150 km(n=190)的患者之间无显著差异;酒精相关肝病在两个距离类别中均为最常见病因(32.9% vs 33.2%;P=0.95)。
- 接受与未接受移植者的MELD-Na评分中位数无差异(17 [IQR 9-25] vs 18 [IQR 10-27];P=0.12)。
- 多变量分析中,距移植中心距离不影响肝移植获得、等待名单死亡或列名后急诊就诊与住院;列名时MELD-Na评分是等待名单死亡增加的显著预测因子(HR 1.12;CI 1.09-1.16;P<0.01),肝细胞癌诊断与等待名单死亡降低相关(HR 0.13;CI 0.04-0.45;P<0.01)。
- 距移植中心较远的患者在列名前一年住院次数中位数更高(2 vs 1;P=0.02)、急诊就诊次数更多(3 vs 2;P<0.01),且列名后90天内急诊利用显著更高(0 [IQR 0-2] vs 0 [IQR 0-1];P<0.05),但多变量分析中不一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Decompensated cirrhosis has a median survival of 2 years without liver transplantation (LT). This study investigates whether distance from LT center affects waitlist mortality and receipt of LT. METHODS: The study population was generated from the transplant database in London, Ontario, Canada. Adult patients on the waitlist for LT between January 1, 2012, and December 31, 2021, were included. Data were linked to the Institute for Clinical Evaluative Sciences to examine clinically relevant outcomes, using ≤150 km vs >150 km to stratify descriptive analysis. Multivariate time-to-event analyses were conducted to evaluate the hazards of increasing distance from LT center on waitlist mortality and receipt of LT. RESULTS: Of the 552 patients meeting study criteria, 394 (71.4%) received LT in an overall predominantly male cohort (n = 390, 70%), with a median age of 59 years (interquartile range [IQR] 52-64) and median distance from the LT center of 110 km (IQR 59-191). There were no significant differences between patients living ≤150 km (n = 362) vs >150 km (n = 190) from the LT center. In liver disease etiology-alcohol-related liver disease remained the most common (32.9% vs 33.2%; P = 0.95) across both categories, with no difference in median Model for End Stage Liver Disease-Sodium scores between those who did and did not receive transplant (17 [IQR 9-25] vs 18 [IQR 10-27]; P = 0.12). On multivariable analysis, distance to the LT center did not affect receipt of LT, waitlist mortality, or postlisting ED visits and hospitalizations. Model for End-Stage Liver Disease-Sodium at listing was a significant predictor of increased waitlist mortality (hazard ratio 1.12; confidence interval 1.09-1.16; P < 0.01), whereas hepatocellular carcinoma diagnosis was associated with reduced waitlist mortality (hazard ratio 0.13; confidence interval 0.04-0.45; P < 0.01). Patients further from the LT center had a higher median number of hospitalizations (2 vs 1; P = 0.02) and emergency department (ED) visits (3 vs 2; P < 0.01) in the year before LT listing, and significantly ED utilization within 90 days postlisting (0 [IQR 0-2] vs 0 [IQR 0-1]; P < 0.05), albeit this was not consistent on multivariable analysis. DISCUSSION: Geographical distance does not significantly affect LT waitlist mortality or receipt of LT. However, differences in healthcare utilization suggest disparities may still manifest with a negative impact on patients in the pre-LT setting.
引用
- Brahmania M, Sachar Y, Arab JP, et al. Geographical Distance From Transplant Center and Impact on Waitlist Outcomes and Healthcare Utilization Prelisting. Am J Gastroenterol. 2025. PMID: 40600978. doi:10.14309/ajg.0000000000003628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。